Oncimmune Holdings plc
ONC.L · LSE
8/31/2024 | 8/31/2023 | 5/31/2022 | 5/31/2021 | |
|---|---|---|---|---|
| Market Cap | £13,012 | £16,822 | £62,933 | £132,694 |
| - Cash | £846 | £3,209 | £2,530 | £8,631 |
| + Debt | £5,122 | £5,301 | £10,686 | £9,468 |
| Enterprise Value | £17,288 | £18,914 | £71,089 | £133,531 |
| Revenue | £2,739 | £1,152 | £3,859 | £3,722 |
| % Growth | 137.8% | -70.1% | 3.7% | – |
| Gross Profit | £1,231 | £792 | £1,457 | £2,857 |
| % Margin | 44.9% | 68.8% | 37.8% | 76.8% |
| EBITDA | -£3,001 | -£4,431 | -£8,389 | -£4,002 |
| % Margin | -109.6% | -384.6% | -217.4% | -107.5% |
| Net Income | -£3,628 | £4,104 | -£9,512 | -£4,628 |
| % Margin | -132.5% | 356.3% | -246.5% | -124.3% |
| EPS Diluted | -0.049 | 0.057 | -0.15 | -0.072 |
| % Growth | -186.4% | 137.7% | -109.2% | – |
| Operating Cash Flow | -£3,381 | -£6,791 | -£6,211 | -£4,527 |
| Capital Expenditures | -£9 | -£31 | -£504 | -£1,071 |
| Free Cash Flow | -£3,390 | -£6,822 | -£6,715 | -£5,598 |